Endo CFO Stepping Down

Malvern, Pa.-based Endo Health Solutions (NASDAQ: ENDP  ) is looking for a new CFO.

On Wednesday, Endo announced that Executive Vice President and Chief Financial Officer Alan G. Levin will soon be leaving the company after a four-year stint to spend more time on "corporate board service and philanthropy, while traveling and spending more time with [his] family."

In a statement, Chief Executive Officer Rajiv De Silva thanked Levin for his service and credited him with helping to build Endo into "one of the leading public diversified health care companies."

Unprofitable Endo has lost $637 million over the past year, and it experienced meager 2.6% revenue growth in its most recent quarter. Over the past year, its stock has underperformed the S&P 500 by nearly 20 percentage points.

A search for a new CFO is under way.

Read/Post Comments (0) | Recommend This Article (0)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2459186, ~/Articles/ArticleHandler.aspx, 9/26/2016 1:45:06 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,107.43 -154.02 -0.84%
S&P 500 2,148.03 -16.66 -0.77%
NASD 5,259.96 -45.79 -0.86%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 1:29 PM
ENDP $22.00 Down -1.39 -5.94%
Endo International CAPS Rating: ****